Skip to main content
. Author manuscript; available in PMC: 2014 Jun 10.
Published in final edited form as: Crit Rev Immunol. 2013;33(4):361–378. doi: 10.1615/critrevimmunol.2013007444

FIGURE 6.

FIGURE 6

Effect of CD40 agonist treatment on survival of T. gondii-infected IL-21R−/− mice. Wild-type and IL-21R−/− mice were infected perorally with T. gondii cysts. Beginning on day 3 post-infection, mice were treated with CD40 agonist antibody (FGK115) or PBS twice weekly for a 2-week period. Mice were monitored for survival, and data represent two experiments with at least 6 mice per group.